CoCites: A citation-based method for searching scientific literature

Paradigm shift in heart failure treatment: are cardiologists ready to use gliflozins?

Michele Correale, Renata Petroni, Stefano Coiro, Elena-Laura Antohi, Francesco Monitillo, Marta Leone, Marco Triggiani, Shiro Ishihara, Hans-Dirk Dungen, Chaudhry M S Sarwar, Maurizio Memo, Hani N Sabbah, Marco Metra, Javed Butler, Savina Nodari. Heart Fail Rev 2022
Times Cited: 3

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.

Milton Packer, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Stuart J Pocock, Peter Carson, James Januzzi, Subodh Verma, Hiroyuki Tsutsui, Martina Brueckmann, Waheed Jamal, Karen Kimura, Janet Schnee, Cordula Zeller, Daniel Cotton, Edimar Bocchi, Michael Böhm, Dong-Ju Choi, Vijay Chopra, Eduardo Chuquiure, Nadia Giannetti, Stefan Janssens, Jian Zhang, Jose R Gonzalez Juanatey, Sanjay Kaul, Hans-Peter Brunner-La Rocca, Bela Merkely, Stephen J Nicholls, Sergio Perrone, Ileana Pina, Piotr Ponikowski, Naveed Sattar, Michele Senni, Marie-France Seronde, Jindrich Spinar, Iain Squire, Stefano Taddei, Christoph Wanner, Faiez Zannad. N Engl J Med 2020
Times Cited: 1096

List of shared articles

Times cited

Effect of empagliflozin on myocardial structure and function in patients with type 2 diabetes at high cardiovascular risk: the SIMPLE randomized clinical trial.
Mads Ersbøll, Mikkel Jürgens, Philip Hasbak, Andreas Kjær, Emil Wolsk, Bo Zerahn, Niels H Brandt-Jacobsen, Peter Gæde, Peter Rossing, Jens Faber,[...]. Int J Cardiovasc Imaging 2022

Redefining diabetes mellitus treatments according to different mechanisms beyond hypoglycaemic effect.
Savina Nodari, Francesco Fioretti, Francesco Barilla. Heart Fail Rev 2022

Sodium-Glucose Cotransporter-2 Inhibitors Improve Heart Failure with Reduced Ejection Fraction Outcomes by Reducing Edema and Congestion.
Michelle Hernandez, Ryan D Sullivan, Mariana E McCune, Guy L Reed, Inna P Gladysheva. Diagnostics (Basel) 2022